Successful outcome of disseminated Fusatium infection with skin localization treated with voriconazole and amphotericin B-Lipid complex in a patient with acute leukemia

被引:55
作者
Durand-Joly, I
Alfandari, S
Benchikh, Z
Rodrigue, M
Espinel-Ingroff, A
Catteau, B
Cordevant, C
Camus, D
Dei-Cas, E
Bauters, F
Delhaes, L
De Botton, S
机构
[1] Fac Med Lille, F-59045 Lille, France
[2] CHRU Lille, Serv Dermatol, Lille, France
[3] CHRU Lille, Serv Malad Sang, Lille, France
[4] Inst Pasteur, IFR17, EA 3609, F-59019 Lille, France
[5] Malad Infect, Tourcoing, France
[6] Virginia Commonwealth Univ Med Coll Virginia, Med Mycol Res Lab, Richmond, VA USA
关键词
D O I
10.1128/JCM.41.10.4898-4900.2003
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
A disseminated Fusarium oxysporum infection with skin localization was diagnosed in a woman with a relapse of B-acute leukemia during induction chemotherapy. The infection was refractory to amphotericin B-lipid complex alone but responded successfully when voriconazole was added.
引用
收藏
页码:4898 / 4900
页数:3
相关论文
共 19 条
[1]  
ANAISSIE E, 1986, CANCER-AM CANCER SOC, V57, P2141, DOI 10.1002/1097-0142(19860601)57:11&lt
[2]  
2141::AID-CNCR2820571110&gt
[3]  
3.0.CO
[4]  
2-N
[5]   Microdilution susceptibility testing of amphotericin B, itraconazole, and voriconazole against clinical isolates of Aspergillus and Fusarium species [J].
Arikan, S ;
Lozano-Chiu, M ;
Paetznick, V ;
Nangia, S ;
Rex, JH .
JOURNAL OF CLINICAL MICROBIOLOGY, 1999, 37 (12) :3946-3951
[6]   Fusarium, a significant emerging pathogen in patients with hematologic malignancy: Ten years' experience at a cancer center and implications for management [J].
Boutati, EI ;
Anaissie, EJ .
BLOOD, 1997, 90 (03) :999-1008
[7]  
DEICAS E, 1991, MYCOSES, V34, P167, DOI 10.1111/j.1439-0507.1991.tb00638.x
[8]   Efficacy and safety of voriconazole in the treatment of acute invasive aspergillosis [J].
Denning, DW ;
Ribaud, P ;
Milpied, N ;
Caillot, D ;
Herbrecht, R ;
Thiel, E ;
Haas, A ;
Ruhnke, M ;
Lode, H .
CLINICAL INFECTIOUS DISEASES, 2002, 34 (05) :563-571
[9]   In vitro antifungal activities of voriconazole and reference agents as determined by NCCLS methods: Review of the literature [J].
Espinel-Ingroff, A ;
Boyle, K ;
Sheehan, DJ .
MYCOPATHOLOGIA, 2001, 150 (03) :101-115
[10]  
Girmenia C, 1999, HAEMATOLOGICA, V84, P114